1.
Product Overview
2. Research Methodology
3. Impact of COVID-19
on Asia-Pacific Cancer Diagnostics Market
4.
Executive Summary
5.
Voice of Customer
6.
Asia-Pacific Cancer Diagnostics Market Outlook
6.1. Market Size &
Forecast
6.1.1. By Value
6.2. Market Share &
Forecast
6.2.1. By Diagnostic Type
(Lab Testing, Genetic Testing, Imaging Testing, Biomarkers Testing, In Vitro
Diagnostic Testing, Biopsy and Others)
6.2.2. By Technology
(Platform Based, Instrument Based, Tumor Biomarker Tests)
6.2.3. By Application (Lung
Cancer, Breast Cancer, Colorectal Cancer, Prostate Cancer, Kidney Cancer, Skin
cancer, Others)
6.2.4. By End-User
(Diagnostic Centers, Hospitals and Clinics, Research Institutes and Others)
6.2.5. By Company
6.2.6. By Country
6.3. Product Market Map
6.4. Asia-Pacific:
Country Analysis
6.4.1. China Cancer Diagnostics Market Outlook
6.4.1.1.
Market Size & Forecast
6.4.1.1.1.
By Value
6.4.1.2.
Market Share & Forecast
6.4.1.2.1.
By Diagnostic Type
6.4.1.2.2.
By Technology
6.4.1.2.3.
By Application
6.4.1.2.4.
By End User
6.4.2. India Cancer Diagnostics Market Outlook
6.4.2.1.
Market Size & Forecast
6.4.2.1.1.
By Value
6.4.2.2.
Market Share & Forecast
6.4.2.2.1.
By Diagnostic Type
6.4.2.2.2.
By Technology
6.4.2.2.3.
By Application
6.4.2.2.4.
By End User
6.4.3. Japan Cancer Diagnostics Market Outlook
6.4.3.1.
Market Size & Forecast
6.4.3.1.1.
By Value
6.4.3.2.
Market Share & Forecast
6.4.3.2.1.
By Diagnostic Type
6.4.3.2.2.
By Technology
6.4.3.2.3.
By Application
6.4.3.2.4.
By End User
6.4.4. South Korea Cancer Diagnostics Market Outlook
6.4.4.1.
Market Size & Forecast
6.4.4.1.1.
By Value
6.4.4.2.
Market Share & Forecast
6.4.4.2.1.
By Diagnostic Type
6.4.4.2.2.
By Technology
6.4.4.2.3.
By Application
6.4.4.2.4.
By End User
6.4.5. Australia Cancer Diagnostics Market Outlook
6.4.5.1.
Market Size & Forecast
6.4.5.1.1.
By Value
6.4.5.2.
Market Share & Forecast
6.4.5.2.1.
By Diagnostic Type
6.4.5.2.2.
By Technology
6.4.5.2.3.
By Application
6.4.5.2.4.
By End User
6.4.6. Singapore Cancer Diagnostics Market Outlook
6.4.6.1.
Market Size & Forecast
6.4.6.1.1.
By Value
6.4.6.2.
Market Share & Forecast
6.4.6.2.1.
By Diagnostic Type
6.4.6.2.2.
By Technology
6.4.6.2.3.
By Application
6.4.6.2.4.
By End User
6.4.7. Malaysia Cancer Diagnostics Market Outlook
6.4.7.1.
Market Size & Forecast
6.4.7.1.1.
By Value
6.4.7.2.
Market Share & Forecast
6.4.7.2.1.
By Diagnostic Type
6.4.7.2.2.
By Technology
6.4.7.2.3.
By Application
6.4.7.2.4.
By End User
6.4.8. Indonesia Cancer Diagnostics Market Outlook
6.4.8.1.
Market Size & Forecast
6.4.8.1.1.
By Value
6.4.8.2.
Market Share & Forecast
6.4.8.2.1.
By Diagnostic Type
6.4.8.2.2.
By Technology
6.4.8.2.3.
By Application
6.4.8.2.4.
By End User
6.4.9. Philippines Cancer Diagnostics Market Outlook
6.4.9.1.
Market Size & Forecast
6.4.9.1.1.
By Value
6.4.9.2.
Market Share & Forecast
6.4.9.2.1.
By Diagnostic Type
6.4.9.2.2.
By Technology
6.4.9.2.3.
By Application
6.4.9.2.4.
By End User
6.4.10. Thailand Cancer Diagnostics Market Outlook
6.4.10.1. Market Size &
Forecast
6.4.10.1.1.
By Value
6.4.10.2. Market Share &
Forecast
6.4.10.2.1.
By Diagnostic Type
6.4.10.2.2.
By Technology
6.4.10.2.3.
By Application
6.4.10.2.4.
By End User
7.
Market Dynamics
7.1. Drivers
7.2. Challenges
8.
Market Trends & Developments
9.
Asia-Pacific Economic Profile
10.
Policy & Regulatory
11.
Competitive Landscape
11.1.
Thermo Fisher
Scientific, Inc.
11.2.
GE Healthcare (A
Subsidiary of General Electric Company)
11.3.
Abbott
Laboratories, Inc.
11.4.
Becton,
Dickinson and Company
11.5.
Siemens AG
11.6.
Agilent
Technologies, Inc.
11.7.
F. Hoffmann-La
Roche Ltd.
11.8.
Bio Rad Laboratories Inc.
11.9.
Illumina, Inc.
11.10.
Boehringer-Ingelheim
International GmbH
12.
Strategic Recommendations
In case you don’t find what you are looking for, please get in touch with our custom research team at sales@techsciresearch.com